Lacking trust in security, privacy reduces patient trust in health IT

Privacy and security concerns are linked to reduced patient access of health records and trust in health information technology (HIT). Findings were published April 11 in the Journal of Medical Internet Research.

In this study, researchers examined the effectiveness of HIT by looking at information assurance issues such as privacy concerns and trust in health information.

 

“Today, the healthcare industry primarily relies on HITs such as electronic medical record (EMR) systems, patient health record (PHR) systems, and technical devices to deliver patient care services,” wrote first author Victoria Kisekka, PhD, and colleagues. “Despite the continued diffusion of HITs within the health care sector, there is no theory explaining how HIT success influences perceived patient care quality.”

The study included data from 3,677 cancer patients from a public dataset. Researchers examined the data for correlations between information assurance and attitudes toward health information exchange (HIE), patient access to health records and perceived patient care quality.

Results showed increased privacy concerns of HIT reduced the frequency patients accessed their health records, positive attitudes toward the HIE and perceptions of patient care quality. However, the belief in the effectiveness of security increased patient access to health records and positive attitudes toward HIE. Trust in health information also had a positive correlation with perceptions of HIE and care quality.

“Trust in health information and belief in the effectiveness of information security safeguards increases perceptions of patient care quality,” concluded Kisekka and colleagues. “Privacy concerns reduce patients’ frequency of accessing health records, patients’ positive attitudes toward HIE exchange, and overall perceived patient care quality. Health care organizations are encouraged to implement security safeguards to increase trust, the frequency of health record use, and reduce privacy concerns, consequently increasing patient care quality.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.